PROFID EHRA trial aims to personalize the prevention of sudden cardiac death after myocardial infarction

The first clinical trial to challenge the routine implantation of a defibrillator in myocardial infarction survivors with heart failure has enrolled its first patient.

Opinion | Think Twice Before Drug Testing Your Black Patients

Zha is a family medicine doctor and a nonfiction writer. “We were stripped naked. We were asked to cough. It was like a movie…We knew

February 6, 2024

Biogen to halt sales and development of controversial Alzheimer’s drug Aduhelm

Biogen will stop sales and development of its controversial Alzheimer’s drug Aduhelm, walking away from a drug that was approved against outside experts’ advice, led

February 1, 2024

Therapeutic targets that impact both cardiac and cerebral functions in CNS neurological disorders

Recent advancements highlight the intricate interplay between the heart and brain, underscoring their profound influence on each other, especially concerning central nervous system (CNS) neurological

August 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.